OpenURL Connection Search

Select item for more details and to access through your institution.

Whole-body diffusion-weighted imaging in lymphoma.
Published in:
2010
By:
- Lin C;
- Itti E;
- Luciani A;
- Haioun C;
- Meignan M;
- Rahmouni A;
- Lin, C;
- Itti, E;
- Luciani, A;
- Haioun, C;
- Meignan, M;
- Rahmouni, A
Publication type:
journal article
Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma.
Published in:
2010
By:
- Lin C;
- Luciani A;
- Itti E;
- El-Gnaoui T;
- Vignaud A;
- Beaussart P;
- Lin SJ;
- Belhadj K;
- Brugières P;
- Evangelista E;
- Haioun C;
- Meignan M;
- Rahmouni A;
- Lin, Chieh;
- Luciani, Alain;
- Itti, Emmanuel;
- El-Gnaoui, Taoufik;
- Vignaud, Alexandre;
- Beaussart, Pauline;
- Lin, Shih-jui
Publication type:
journal article
Value of [18F]fluorodeoxyglucose-positron emission tomography in managing patients with aggressive non-Hodgkin's lymphoma.
Published in:
2006
By:
- Meignan M;
- Haioun C;
- Itti E;
- Rahmouni A;
- Reyes F
Publication type:
Journal Article
Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study.
Published in:
Bone Marrow Transplantation, 2000, v. 25, n. 3, p. 251, doi. 10.1038/sj.bmt.1702135
By:
- Decaudin, D;
- Brousse, N;
- Brice, P;
- Haioun, C;
- Bourhis, J-H;
- Morel, P;
- Van Hoof, A;
- Souleau, B;
- Quesnel, B;
- Gisselbrecht, C
Publication type:
Article
Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell lymphoproliferative disorder.
Published in:
1988
By:
- Gaulard, P;
- Henni, T;
- Marolleau, J P;
- Haioun, C;
- Henni, Z;
- Voisin, M C;
- Divine, M;
- Goossens, M;
- Farcet, J P;
- Reyes, F
Publication type:
journal article
Immunoblastic lymphoma involving the bone marrow in a patient with alpha chain disease. Clinical and immunoelectron microscopic study.
Published in:
1985
By:
- Reyes, Félix;
- Piquet, Jacques;
- Gourdin, Marie Françloise;
- Haioun, Corinne;
- Intrator, Liliane;
- Tulliez, Michel;
- Roberti, Andréa;
- Rambaud, Jean Claude;
- Reyes, F;
- Piquet, J;
- Gourdin, M F;
- Haioun, C;
- Intrator, L;
- Tulliez, M;
- Roberti, A;
- Rambaud, J C
Publication type:
journal article
Imagerie par résonance magnétique (IRM) corps entier en cancérologie.
Published in:
Oncologie (Tech Science Press), 2007, v. 9, n. 4, p. 286, doi. 10.1007/s10269-007-0640-2
By:
- Lin, C.;
- Luciani, A.;
- Haioun, C.;
- Pigneur, F.;
- Deux, J.;
- Zerbib, P.;
- Vignaud, A.;
- Raymond, R.;
- Kobeiter, H.;
- Itti, E.;
- Rahmouni, A.
Publication type:
Article
Hematopoietic growth factors in treatment of necrotizing cellulitis patients with drug-induced neutropenia.
Published in:
1993
By:
- Souidi, F.;
- Chosidow, O.;
- Cordonnier, C.;
- Haioun, C.;
- Roujeau, J.C.;
- Revuz, J.
Publication type:
journal article
Current status and future perspectives for yttrium-90 (90Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 11, p. 1007, doi. 10.1038/sj.bmt.1705868
By:
- Gisselbrecht, C.;
- Bethge, W.;
- Duarte, R. F.;
- Gianni, A. M.;
- Glass, B.;
- Haioun, C.;
- Martinelli, G.;
- Nagler, A.;
- Pettengell, R.;
- Sureda, A.;
- Tilly, H.;
- Wilson, K.
Publication type:
Article
Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial.
Published in:
2010
By:
- Rolland D;
- Ribrag V;
- Haioun C;
- Ghesquieres H;
- Jardin F;
- Bouabdallah R;
- Franchi P;
- Briere J;
- De Kerviler E;
- Chassagne-Clement C;
- Raponi M;
- Houlgatte R;
- Jais JP;
- Thieblemont C;
- Rolland, Delphine;
- Ribrag, Vincent;
- Haioun, Corinne;
- Ghesquieres, Herve;
- Jardin, Fabrice;
- Bouabdallah, Reda
Publication type:
journal article
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.
Published in:
Leukemia (08876924), 2014, v. 28, n. 12, p. 2367, doi. 10.1038/leu.2014.137
By:
- Rossille, D;
- Gressier, M;
- Damotte, D;
- Maucort-Boulch, D;
- Pangault, C;
- Semana, G;
- Le Gouill, S;
- Haioun, C;
- Tarte, K;
- Lamy, T;
- Milpied, N;
- Fest, T
Publication type:
Article
Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.
Published in:
Leukemia (08876924), 2013, v. 27, n. 1, p. 252, doi. 10.1038/leu.2012.172
By:
- Tilly, H;
- Morschhauser, F;
- Salles, G;
- Casasnovas, R-O;
- Feugier, P;
- Molina, T J;
- Jardin, F;
- Terriou, L;
- Haioun, C;
- Coiffier, B
Publication type:
Article
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages.
Published in:
2009
By:
- Carbonnelle-Puscian, A.;
- Copie-Bergman, C.;
- Baia, M.;
- Martin-Garcia, N.;
- Allory, Y.;
- Haioun, C.;
- Crémades, A.;
- Abd-Alsamad, I.;
- Farcet, J.-P.;
- Gaulard, P.;
- Castellano, F.;
- Molinier-Frenkel, V.;
- Crémades, A
Publication type:
journal article
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
Published in:
2008
By:
- Jais, J.-P.;
- Haioun, C.;
- Molina, T. J.;
- Rickman, D. S.;
- de Reynies, A.;
- Berger, F.;
- Gisselbrecht, C.;
- Brière, J.;
- Reyes, F.;
- Gaulard, P.;
- Feugier, P.;
- Labouyrie, E.;
- Tilly, H.;
- Bastard, C.;
- Coiffier, B.;
- Salles, G.;
- Leroy, K.;
- Brière, J;
- Groupe d'Etude des Lymphomes de l'Adulte
Publication type:
journal article
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study.
Published in:
Leukemia (08876924), 2007, v. 21, n. 11, p. 2324, doi. 10.1038/sj.leu.2404850
By:
- Montoto, S.;
- Canals, C.;
- Rohatiner, A. Z. S.;
- Taghipour, G.;
- Sureda, A.;
- Schmitz, N.;
- Gisselbrecht, C.;
- Fouillard, L.;
- Milpied, N.;
- Haioun, C.;
- Slavin, S.;
- Conde, E.;
- Fruchart, C.;
- Ferrant, A.;
- Leblond, V.;
- Tilly, H.;
- Lister, T. A.;
- Goldstone, A. H.
Publication type:
Article
Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literature.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2015, v. 29, n. 1, p. 77, doi. 10.1111/jdv.12454
By:
- Ingen ‐ Housz ‐ Oro, S.;
- Franck, N.;
- Beneton, N.;
- Fauconneau, A.;
- Do ‐ Pham, G.;
- Carlotti, A.;
- Petit, T.;
- Liolios, I.;
- Bara, C.;
- Carpentier, H.;
- Storelli, D.;
- Prophette, B.;
- Garderet, L.;
- Haioun, C.;
- Petit, E.;
- Delfau ‐ Larue, M. ‐ H.;
- Vergier, B.;
- Chosidow, O.;
- Beylot ‐ Barry, M.;
- Ortonne, N.
Publication type:
Article
PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R‐CHOP IN PATIENTS (PTS) WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): EPCORE DLBCL‐2.
Published in:
Hematological Oncology, 2023, v. 41, p. 849, doi. 10.1002/hon.3166_OT28
By:
- Sehn, L. H;
- Chamuleau, M.;
- Lenz, G.;
- Clausen, M. R.;
- Haioun, C.;
- Izutsu, K.;
- Davies, A.;
- Zhu, J.;
- Oki, T.;
- Szafer‐Glusman, E.;
- Conlon, R.;
- Chiou, H.;
- Ipe, D.;
- Elliot, B.;
- Wu, J.;
- Salles, G.
Publication type:
Article
MOLECULAR CHARACTERIZATION CONTRIBUTES TO DIAGNOSIS AND PREDICTS OUTCOME IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMAS: A LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 110, doi. 10.1002/hon.3163_70
By:
- Camus, V.;
- Viailly, P.;
- Sesques, P.;
- Drieux, F.;
- Veresezan, E.;
- Haioun, C.;
- Durot, E.;
- Patey, M.;
- Rossi, C.;
- Martin, L.;
- Rainville, V.;
- Bohers, E.;
- Ruminy, P.;
- Viennot, M.;
- Paillassa, J.;
- Tournilhac, O.;
- Willaume, A.;
- Antier, C.;
- Lazarovici, J.;
- Lévêque, E.
Publication type:
Article
RADIOMICS REFLECTING BOTH TUMOR AND HOST FEATURES IMPROVES OUTCOME PREDICTION IN FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 94, doi. 10.1002/hon.3163_58
By:
- Rebaud, L.;
- Capobianco, N.;
- Spottiswoode, B.;
- Cottereau, A.;
- Trotman, J.;
- Feugier, P.;
- Nastoupil, L. J.;
- Bachy, E.;
- Flinn, I. W.;
- Haioun, C.;
- Ysebaert, L.;
- Bartlett, N. L.;
- Tilly, H.;
- Casasnovas, R.;
- Ricci, R.;
- Portugues, C.;
- Meignan, M.;
- Morschhauser, F.;
- Buvat, I.
Publication type:
Article
Tafasitamab lenalidomide in relapsed/refractory large B‐cell lymphomas: a multicentric real‐world French experience study.
Published in:
Hematological Oncology, 2023, v. 41, p. 591, doi. 10.1002/hon.3164_443
By:
- Paillassa, J.;
- Degoutte, C.;
- Oberic, L.;
- Branche, N.;
- Copin, M.;
- Poullot, E.;
- Laurent, C.;
- Lacheretz, V.;
- Haioun, C.;
- Herbaux, C.
Publication type:
Article
REALMA: Subset of patients with Marginal Zone Lymphomas from the French nationwide REALYSA real‐world prospective cohort.
Published in:
Hematological Oncology, 2023, v. 41, p. 387, doi. 10.1002/hon.3164_281
By:
- Bommier, C.;
- Donzel, M.;
- Rossi, C.;
- Fornecker, L.;
- Bijou, F.;
- Chauchet, A.;
- Lebras, L.;
- Ysebaert, L.;
- Haioun, C.;
- Bouabdallah, K.;
- Morineau, N.;
- Gastinne, T.;
- Amorim, S.;
- Jardin, F.;
- Abraham, J.;
- Lamy de la Chapelle, T.;
- Gressin, R.;
- Fouillet, L.;
- Fruchart, C.;
- Morschhauser, F.
Publication type:
Article
Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype in the RT3 and REMARC trials—A LYSA retrospective analysis.
Published in:
Hematological Oncology, 2023, v. 41, p. 346, doi. 10.1002/hon.3164_248
By:
- Willaume, A.;
- Chartier, L.;
- Ricci, R.;
- Blanc‐Durand, P.;
- Amorim, S.;
- Haioun, C.;
- Thieblemont, C.;
- Legouill, S.;
- Casasnovas, O.;
- Morschhauser, F.;
- Jardin, F.;
- Pascal, L.
Publication type:
Article
VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 151, doi. 10.1002/hon.3163_100
By:
- Sarkozy, C.;
- Thieblemont, C.;
- Oberic, L.;
- Moreau, A.;
- Bouabdallah, K.;
- Damaj, G.;
- Gastine, T.;
- Ribrag, V.;
- Casasnovas, O.;
- Haioun, C.;
- Houot, R.;
- Jardin, F.;
- Van Den Neste, E.;
- Cheminant, M.;
- Morschhauser, F.;
- Callana, M.;
- Ghesquieres, H.;
- Gressin, R.;
- Hermine, O.;
- Le Gouill, S.
Publication type:
Article
LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.96_2880
By:
- Camus, V.;
- Belot, Aurél.;
- Oberic, L.;
- Sibon, D.;
- Ghesquières, H.;
- Thieblemont, C.;
- Fruchart, C.;
- Casasnovas, O.;
- Michot, Jean‐M.;
- Molina, T. J.;
- Bosly, A.;
- Joubert, Clém.;
- Haioun, C.;
- Delarue, R.;
- Tilly, H.
Publication type:
Article
OUTCOMES AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.50_2879
By:
- Camus, V.;
- Rossi, C.;
- Sesques, P.;
- Lequesne, J.;
- Tonnelet, D.;
- Haioun, C.;
- Durot, E.;
- Willaume, A.;
- Gauthier, M.;
- Moles‐Moreau, Marie‐P.;
- Antier, C.;
- Lazarovici, J.;
- Monjanel, H.;
- Bernard, S.;
- Tardy, M.;
- Besson, C.;
- Lebras, L.;
- Choquet, S.;
- Le Du, K.;
- Bonnet, C.
Publication type:
Article
EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.5_2879
By:
- Bologna, S;
- Vander Borght, T;
- Briere, J;
- Ribrag, V;
- Damaj, G. L;
- Thieblemont, C;
- Feugier, P;
- Peyrade, F;
- Lebras, L;
- Coso, D;
- Sibon, D;
- Bonnet, C;
- Morschhauser, F;
- Ghesquieres, H;
- Becker, S;
- Olivier, P;
- Fabiani, B;
- Tilly, H;
- Haioun, C;
- Bastie, J. N
Publication type:
Article
CIRCULATING TUMOR DNA LOAD AND TOTAL METABOLIC TUMOR VOLUME IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) PATIENTS TREATED BY R‐CHOP – FROM REMARC, A LYSA STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.3_2880
By:
- Bohers, E;
- Delfau‐Larue, M;
- Vercellino, L;
- Cottereau, A;
- Viennot, M;
- Viailly, P;
- Salles, G;
- Tilly, H;
- Damaj, G;
- Haioun, C;
- Ribrag, V;
- Morschhauser, F;
- Casasnovas, R;
- Nicolas‐Virelizier, E;
- Feugier, P;
- Bouabdallah, R;
- Cartron, G;
- Renaud, L;
- Chartier, L;
- Portugues, C
Publication type:
Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.22_2880
By:
- Cartron, G.;
- Bachy, E.;
- Guidez, S.;
- Gyan, E.;
- Gressin, R.;
- Morineau, N.;
- Sibon, D.;
- Casasnovas, O.;
- Le Gouill, S.;
- Tilly, H.;
- Ysebaert, L.;
- Schiano de Colella, J. M.;
- Feugier, P.;
- Virelizier, E. Nicolas;
- Haioun, C.;
- Damaj, G.;
- Tarte, K.;
- Laurent, C.;
- Houot, R.;
- Thieblemont, C.
Publication type:
Article
BASELINE CIRCULATING TUMOUR DNA AND TOTAL METABOLIC TUMOUR VOLUME AS EARLY OUTCOME PREDICTORS IN AGGRESSIVE B‐CELL LYMPHOMA. A REAL LIFE PROSPECTIVE 112‐PATIENT COHORT.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.2_2880
By:
- Le Goff, E;
- Blanc‐Durand, P;
- Roulin, L;
- Loyaux, R;
- MBoumbae, D. L;
- Poullot, E;
- Robe, C;
- Benmaad, I;
- Gricourt, G;
- Aissat, A;
- Copie‐Bergman, C;
- Lemonnier, F;
- Gaulard, P;
- Itti, E;
- Haioun, C;
- Delfau Larue, M.‐H
Publication type:
Article
GENDER DISPARITIES IN QUALITY OF LIFE OF FRENCH PATIENTS ONE YEAR AFTER THE DIAGNOSIS OF LYMPHOMA. A LYSA STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.192_2880
By:
- Paunescu, A.‐C.;
- Paget, J.;
- Bergman, C. Copie;
- Malak, S.;
- Le Gouill, S.;
- Ribrag, V.;
- Bouabdallah, K.;
- Sibon, D.;
- Rumpold, G.;
- Preau, M.;
- Mounier, N.;
- Haioun, C.;
- Jardin, F.;
- Besson, C.
Publication type:
Article
GLOFITAMAB STEP‐UP DOSING: UPDATED EFFICACY DATA SHOW HIGH COMPLETE RESPONSE RATES IN HEAVILY PRETREATED RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL) PATIENTS.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.15_2879
By:
- Carlo‐Stella, C;
- Hutchings, M;
- Offner, F. C;
- Morschhauser, F;
- Bachy, E;
- Crump, M;
- Sureda, A;
- Iacoboni, G;
- Haioun, C;
- Perez‐Callejo, D;
- Lundberg, L;
- Relf, J;
- Clark, E;
- Carlile, D;
- Piccione, E;
- Belousov, A;
- Humphrey, K;
- Dickinson, M. J
Publication type:
Article
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R2‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
Published in:
Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.93_2629
By:
- Nowakowski, G.;
- Willenbacher, W.;
- Greil, R.;
- Larsen, T.S.;
- Patel, K.;
- Jäger, U.;
- Manges, R.F.;
- Trümper, L.;
- Haioun, C.;
- Everaus, H.;
- Kalakonda, N.;
- Knoble, J.;
- Nully Brown, P.;
- Jørgensen, J.M.;
- Cunningham, D.;
- Domper Rubio, N.;
- Casadebaig, M.;
- Manzke, O.;
- Munoz, J.
Publication type:
Article
BONE MARROW INVOLVEMENT, BUT NO BLOOD INVOLVEMENT, IMPAIRS SURVIVAL IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: AN ANCILLARY STUDY OF THE REVAIL TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 278, doi. 10.1002/hon.89_2630
By:
- Lemonnier, F.;
- Safar, V.;
- Ferchiou, A.;
- Cottereau, A.;
- Bachy, E.;
- Cartron, G.;
- Moles‐Moreau, M.;
- Delmer, A.;
- Bouabdallah, R.;
- Voillat, L.;
- Parrens, M.;
- Casasnovas, O.;
- Cacheux, V.;
- Réguy, C.;
- Tilly, H.;
- Meignan, M.;
- Gaulard, P.;
- Leval, L.;
- Delfau‐Larrue, M.;
- Haioun, C.
Publication type:
Article
RITUXIMAB PLUS LENALIDOMIDE IS AS EFFECTIVE AS IMMUNOCHEMOTHERAPY IN THE ERADICATION OF MOLECULAR DISEASE IN UNTREATED FOLLICULAR LYMPHOMA: RELEVANCE LYSA ANCILLARY STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 117, doi. 10.1002/hon.77_2629
By:
- Delfau‐Larue, M.H.;
- Boulland, M.L.;
- Feugier, P.;
- Maisonneuve, H.;
- Casasnovas, O.;
- Haioun, C.;
- Pica, G.M.;
- Lamy de la Chapelle, T.;
- Ysebaert, L.;
- Tilly, H.;
- Eisenmann, J.C.;
- Le Gouil, S.;
- Ribrag, V.;
- Jardel, H.;
- Glaisner, S.;
- Cartron, G.;
- Salles, G.;
- Xerri, L.;
- Fest, T.;
- Morschhauser, F.
Publication type:
Article
COMPARISON OF CLINICAL SCORING SYSTEMS IN AGGRESSIVE B‐CELL LYMPHOMAS (BCL): AN INDIVIDUAL PATIENT‐LEVEL ANALYSIS ACROSS INTERNATIONAL TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 248, doi. 10.1002/hon.57_2630
By:
- Schmitz, N.F.;
- Dixon, J.G.;
- Salles, G.;
- Wall, A.;
- Cunningham, D.;
- Poeschel, V.;
- Haioun, C.;
- Tilly, H.;
- Ghesquieres, H.;
- Ziepert, M.;
- Flament, J.;
- Flowers, C.;
- Shi, Q.;
- Ruppert, A.S.
Publication type:
Article
THE CLINICAL COURSE OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) OVER TIME: A MULTISTATE SURVIVAL ANALYSIS USING META‐DATA FROM 13 FIRST‐LINE RANDOMIZED TRIALS.
Published in:
Hematological Oncology, 2019, v. 37, p. 247, doi. 10.1002/hon.56_2630
By:
- Çağlayan, Ç.;
- Dixon, J.G.;
- Salles, G.;
- Wall, A.;
- Schmitz, N.;
- Cunningham, D.;
- Poeschel, V.;
- Seymour, J.;
- Jaeger, U.;
- Habermann, T.;
- Merli, F.;
- Haioun, C.;
- Tilly, H.;
- Ghesiquieres, H.;
- Ziepert, M.;
- Flament, J.;
- Shi, Q.;
- Flowers, C.
Publication type:
Article
JAK‐STAT PATHWAY AND EPIGENETIC REGULATORS ARE CRITICAL PLAYERS IN BI‐ALCL PATHOGENESIS?
Published in:
Hematological Oncology, 2019, v. 37, p. 201, doi. 10.1002/hon.16_2630
By:
- Laurent, C.;
- Nicolae, A.;
- Le Bras, F.;
- Haioun, C.;
- Fataccioli, V.;
- Amara, N.;
- Adélaïde, J.;
- Guille, A.;
- Schiano De Colella, J.;
- Tesson, B.;
- Traverse‐Glehen, A.;
- Chenard, M.;
- Mescam, L.;
- Moreau, A.;
- Chassagne‐Clément, C.;
- Somja, J.;
- Escudié, F.;
- André, M.;
- Martin, N.;
- Hamy‐Petit, A.
Publication type:
Article
CLINICAL, IMMUNOPHENOTYPIC AND GENETIC CHARACTERISTICS OF AGGRESSIVE (NON‐BURKITT) B‐CELL LYMPHOMA IN A REAL LIFE COHORT.
Published in:
Hematological Oncology, 2019, v. 37, p. 351, doi. 10.1002/hon.13_2631
By:
- Roulin, L.;
- Jais, J.;
- Poullot, E.;
- Robe, C.;
- Scherman, E.;
- Lemonnier, F.;
- Le Bras, F.;
- Maarek, A.;
- Belhadj, K.;
- Dupuis, J.;
- Hammoud, M.;
- El Gnaoui, T.;
- Mule, S.;
- Itti, E.;
- Delfau‐Larue, M.;
- Gaulard, P.;
- Haioun, C.;
- Copie‐Bergman, C.
Publication type:
Article
REFINEMENT OF MUM1 EXPRESSION THRESHOLD FOR DOUBLE POSITIVE CD10+ MUM1+ DIFFUSE LARGE B CELL LYMPHOMA ALLOWS A BETTER CELL OF ORIGIN CLASSIFICATION FOR GCB SUBTYPE.
Published in:
Hematological Oncology, 2019, v. 37, p. 197, doi. 10.1002/hon.11_2630
By:
- Bossard, C.;
- Laghmari, O.;
- Le Bris, Y.;
- Bonnet, A.;
- Moreau, A.;
- El Alami Thomas, W.;
- Pavageau, A.;
- Guerzider, P.;
- Maisonneuve, H.;
- Ruminy, P.;
- Bene, M.;
- Casasnovas, O.;
- Canioni, D.;
- Thieblemont, C.;
- Petrella, T.;
- Jardin, F.;
- Salles, G.;
- Tilly, H.;
- Gaulard, P.;
- Haioun, C.
Publication type:
Article
RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN (R‐GemOx) IN REFRACTORY/RELAPSED (R/R) DLBCL. A REAL LIFE STUDY IN PATIENTS INELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION.
Published in:
Hematological Oncology, 2019, v. 37, p. 429, doi. 10.1002/hon.101_2631
By:
- Cazelles, C.;
- Belhadj, K.;
- Vellemans, H.;
- Camus, V.;
- Copi‐Bergman, C.;
- Veresezan, L.;
- Itti, E.;
- Becker, S.;
- Carvalho, M.;
- Dupuis, J.;
- Fabien, L.;
- Lemonnier, F.;
- Roulin, L.;
- El Gnaoui, T.;
- Jardin, F.;
- Mounier, N.;
- Tilly, H.;
- Haioun, C.
Publication type:
Article
BONE MARROW INVOLVEMENT, BUT NO BLOOD INVOLVEMENT, IMPAIRS SURVIVAL IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: AN ANCILLARY STUDY OF THE REVAIL TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 278, doi. 10.1002/hon.89_2630
By:
- Lemonnier, F.;
- Safar, V.;
- Ferchiou, A.;
- Cottereau, A.;
- Bachy, E.;
- Cartron, G.;
- Moles‐Moreau, M.;
- Delmer, A.;
- Bouabdallah, R.;
- Voillat, L.;
- Parrens, M.;
- Casasnovas, O.;
- Cacheux, V.;
- Réguy, C.;
- Tilly, H.;
- Meignan, M.;
- Gaulard, P.;
- Leval, L.;
- Delfau‐Larrue, M.;
- Haioun, C.
Publication type:
Article
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R2‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
Published in:
Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.93_2629
By:
- Nowakowski, G.;
- Willenbacher, W.;
- Greil, R.;
- Larsen, T.S.;
- Patel, K.;
- Jäger, U.;
- Manges, R.F.;
- Trümper, L.;
- Haioun, C.;
- Everaus, H.;
- Kalakonda, N.;
- Knoble, J.;
- Nully Brown, P.;
- Jørgensen, J.M.;
- Cunningham, D.;
- Domper Rubio, N.;
- Casadebaig, M.;
- Manzke, O.;
- Munoz, J.
Publication type:
Article
RITUXIMAB PLUS LENALIDOMIDE IS AS EFFECTIVE AS IMMUNOCHEMOTHERAPY IN THE ERADICATION OF MOLECULAR DISEASE IN UNTREATED FOLLICULAR LYMPHOMA: RELEVANCE LYSA ANCILLARY STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 117, doi. 10.1002/hon.77_2629
By:
- Delfau‐Larue, M.H.;
- Boulland, M.L.;
- Feugier, P.;
- Maisonneuve, H.;
- Casasnovas, O.;
- Haioun, C.;
- Pica, G.M.;
- Lamy de la Chapelle, T.;
- Ysebaert, L.;
- Tilly, H.;
- Eisenmann, J.C.;
- Le Gouil, S.;
- Ribrag, V.;
- Jardel, H.;
- Glaisner, S.;
- Cartron, G.;
- Salles, G.;
- Xerri, L.;
- Fest, T.;
- Morschhauser, F.
Publication type:
Article
COMPARISON OF CLINICAL SCORING SYSTEMS IN AGGRESSIVE B‐CELL LYMPHOMAS (BCL): AN INDIVIDUAL PATIENT‐LEVEL ANALYSIS ACROSS INTERNATIONAL TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 248, doi. 10.1002/hon.57_2630
By:
- Schmitz, N.F.;
- Dixon, J.G.;
- Salles, G.;
- Wall, A.;
- Cunningham, D.;
- Poeschel, V.;
- Haioun, C.;
- Tilly, H.;
- Ghesquieres, H.;
- Ziepert, M.;
- Flament, J.;
- Flowers, C.;
- Shi, Q.;
- Ruppert, A.S.
Publication type:
Article
THE CLINICAL COURSE OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) OVER TIME: A MULTISTATE SURVIVAL ANALYSIS USING META‐DATA FROM 13 FIRST‐LINE RANDOMIZED TRIALS.
Published in:
Hematological Oncology, 2019, v. 37, p. 247, doi. 10.1002/hon.56_2630
By:
- Çağlayan, Ç.;
- Dixon, J.G.;
- Salles, G.;
- Wall, A.;
- Schmitz, N.;
- Cunningham, D.;
- Poeschel, V.;
- Seymour, J.;
- Jaeger, U.;
- Habermann, T.;
- Merli, F.;
- Haioun, C.;
- Tilly, H.;
- Ghesiquieres, H.;
- Ziepert, M.;
- Flament, J.;
- Shi, Q.;
- Flowers, C.
Publication type:
Article
JAK‐STAT PATHWAY AND EPIGENETIC REGULATORS ARE CRITICAL PLAYERS IN BI‐ALCL PATHOGENESIS?
Published in:
Hematological Oncology, 2019, v. 37, p. 201, doi. 10.1002/hon.16_2630
By:
- Laurent, C.;
- Nicolae, A.;
- Le Bras, F.;
- Haioun, C.;
- Fataccioli, V.;
- Amara, N.;
- Adélaïde, J.;
- Guille, A.;
- Schiano De Colella, J.;
- Tesson, B.;
- Traverse‐Glehen, A.;
- Chenard, M.;
- Mescam, L.;
- Moreau, A.;
- Chassagne‐Clément, C.;
- Somja, J.;
- Escudié, F.;
- André, M.;
- Martin, N.;
- Hamy‐Petit, A.
Publication type:
Article
CLINICAL, IMMUNOPHENOTYPIC AND GENETIC CHARACTERISTICS OF AGGRESSIVE (NON‐BURKITT) B‐CELL LYMPHOMA IN A REAL LIFE COHORT.
Published in:
Hematological Oncology, 2019, v. 37, p. 351, doi. 10.1002/hon.13_2631
By:
- Roulin, L.;
- Jais, J.;
- Poullot, E.;
- Robe, C.;
- Scherman, E.;
- Lemonnier, F.;
- Le Bras, F.;
- Maarek, A.;
- Belhadj, K.;
- Dupuis, J.;
- Hammoud, M.;
- El Gnaoui, T.;
- Mule, S.;
- Itti, E.;
- Delfau‐Larue, M.;
- Gaulard, P.;
- Haioun, C.;
- Copie‐Bergman, C.
Publication type:
Article
REFINEMENT OF MUM1 EXPRESSION THRESHOLD FOR DOUBLE POSITIVE CD10+ MUM1+ DIFFUSE LARGE B CELL LYMPHOMA ALLOWS A BETTER CELL OF ORIGIN CLASSIFICATION FOR GCB SUBTYPE.
Published in:
Hematological Oncology, 2019, v. 37, p. 197, doi. 10.1002/hon.11_2630
By:
- Bossard, C.;
- Laghmari, O.;
- Le Bris, Y.;
- Bonnet, A.;
- Moreau, A.;
- El Alami Thomas, W.;
- Pavageau, A.;
- Guerzider, P.;
- Maisonneuve, H.;
- Ruminy, P.;
- Bene, M.;
- Casasnovas, O.;
- Canioni, D.;
- Thieblemont, C.;
- Petrella, T.;
- Jardin, F.;
- Salles, G.;
- Tilly, H.;
- Gaulard, P.;
- Haioun, C.
Publication type:
Article
RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN (R‐GemOx) IN REFRACTORY/RELAPSED (R/R) DLBCL. A REAL LIFE STUDY IN PATIENTS INELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION.
Published in:
Hematological Oncology, 2019, v. 37, p. 429, doi. 10.1002/hon.101_2631
By:
- Cazelles, C.;
- Belhadj, K.;
- Vellemans, H.;
- Camus, V.;
- Copi‐Bergman, C.;
- Veresezan, L.;
- Itti, E.;
- Becker, S.;
- Carvalho, M.;
- Dupuis, J.;
- Fabien, L.;
- Lemonnier, F.;
- Roulin, L.;
- El Gnaoui, T.;
- Jardin, F.;
- Mounier, N.;
- Tilly, H.;
- Haioun, C.
Publication type:
Article
CLINICAL OUTCOMES AND MOLECULAR CHARACTERIZATION FROM a PHASE II STUDY OF COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 68, doi. 10.1002/hon.2437_56
By:
- Lenz, G.;
- Hawkes, E.;
- Verhoef, G.;
- Haioun, C.;
- Lim, S.;
- Heo, D.;
- Ardeshna, K.;
- Chong, G.;
- Christensen, J.H.;
- Shi, V.;
- Lippert, S.;
- Hiemeyer, F.;
- Piraino, P.;
- Beckmann, G.;
- Peña, C.;
- Buvaylo, V.;
- Childs, B.H.;
- Gorbatchevsky, I.;
- Salles, G.
Publication type:
Article

Found: 64